	The future promise of antibody-drug conjugates in extensive-stage small cell lung cancer. Cancer Sethakorn N, Chiang AC. PMID: 42226003 [PubMed - in process]
	Antibody-drug conjugates in breast cancer. Cancer Sakach EA, Meisel JL, McArthur HL. PMID: 42225999 [PubMed - in process]
	Downplaying toxicities in cancer drug trials is not acceptable. Nat Med Gyawali B. PMID: 42225992 [PubMed - as supplied by publisher]
	Tumor-targeted interferon-Î± gene therapy for glioblastoma: a phase 1 trial. Nat Med Gentner B, Eoli M, Farina F, Barcella M, Capotondo A, Mazzoleni S, Brambilla V, Francavilla A, Garramone M, Carrabba MG, Ferla V, Bruno A, Alvisi G, Coltella N, Montini E, Hadadi L, Capt C, Cuccarini V, Bruzzone MG, Di Meco F, Legnani FG, Ferroli P, Acerbi F, Pallini R, D'Alessandris QG, Olivi A, Gagliardi F, Snider S, Mortini P, Patanè M, Fiocchi A, Berno V, Poliani PL, Finocchiaro G, Russo C, Ciceri F, Naldini L. PMID: 42225991 [PubMed - as supplied by publisher]
	SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial. Nat Med Byers LA, Cho BC, Cooper AJ, Chiang AC, Han JY, Furqan M, Dowlati A, Morgensztern D, Papadopoulos KP, Choudhury NJ, Vieito M, Bar J, Kim JH, Akerley W, Kim TM, Kim YC, Paz-Ares L, Ahn MJ, Yokouchi H, Meiman D, Munasinghe W, Ogunyankin O, Jahchan N, Wang S, Ferlini C, Robinson RR, Kohlhapp FJ, Palenski T, Rivell G, Hingorani P, Chandana S. PMID: 42225988 [PubMed - as supplied by publisher]
	Application of delta radiomics based on cone-beam computed tomography in predicting radiotherapy efficacy for nasopharyngeal carcinoma. Strahlenther Onkol Liao Z, Yin H, Luo D, Xu J, Zeng X, Tang X, Huang F, Zhang X. PMID: 42225987 [PubMed - as supplied by publisher]
	Landmark cancer trial shows success against 'undruggable' cancer - raising hopes for future treatments. Nature Ledford H. PMID: 42225806 [PubMed - as supplied by publisher]
	Predictors of knowledge and attitudes toward palliative care among patients with cancer: a cross-sectional study. Sci Rep Momeni M, Moosavi S, Pakmehr S, Hasandoost F. PMID: 42225778 [PubMed - as supplied by publisher]
	Comparative evaluation of CNN models for nasopharyngeal carcinoma classification on pathology data. Sci Rep Abdullahi MK, Mansor S, Ahmad WSHMW, Nabi MS, Fauzi MFA, Wadood AS, Ismail AM. PMID: 42225742 [PubMed - as supplied by publisher]
	Multi-omics integration model of exosome metabolomics and PD-1/PD-L1 expression for early prediction of immunotherapy efficacy in advanced liver cancer. Sci Rep Li C, Du D, Liu Y, Wang X, Feng Y, Cui P. PMID: 42225720 [PubMed - as supplied by publisher]
	Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial. Signal Transduct Target Ther Zhao Q, Li Y, Zhang H, Han D, Kan Y, Sun H, Liu C, Wang L, Han X, Hua Y, Wang X, Fu C, Wang Z, Du X, Liu J, Li B, Huang W. PMID: 42225651 [PubMed - in process]
	Regulatory T cells in cancer and inflammation. Signal Transduct Target Ther Yang H, Zhang H, Xia N, Cheng X. PMID: 42225638 [PubMed - in process]
	Skin Health in Oncology: Evidence-Based Skin Care for Cancer Patients. Oncologist Kaminsky A, Suhl S, Sacknovitz Y, Schwartz GK, Deverapalli S, Geskin LJ. PMID: 42225610 [PubMed - as supplied by publisher]
	Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directions. Cancer Mansinho A, Albuquerque J, Lopes A, Calvo E. PMID: 42225587 [PubMed - in process]
	From Bench to Bedside: The Path Toward Real-World Translation for Artificial Intelligence in Pancreatic Cancer Detection. Korean J Radiol Syailendra EA, Arshad H, Lopez-Ramirez F, Tixier F, Kawamoto S, Fishman EK, Chu LC. PMID: 42225574 [PubMed - in process]
	MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial. Eur Urol Oncol Boschheidgen M, Al-Monajjed R, Schlemmer HP, Krilaviciute A, Bonekamp D, Herkommer K, Jahnen M, Gschwend JE, Düx D, Wacker F, Makowski MR, Sauter A, Kuczyk MA, Harke N, Debus J, Grott C, Lakes J, Radtke JP, Arsov C, Seibold P, Hadaschik B, Giesel F, Kristiansen G, Benner A, Antoch G, Becker N, Kaaks R, Albers P, Schimmöller L. PMID: 42225542 [PubMed - as supplied by publisher]
	Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer. Semin Nucl Med Sadeghpour S, Saidi B, Sahafi P, Maleki F, Ranjbar S, Ghorbani M, Ghadiri Hakim H, Aghaee A, Fanti S, Beheshti M, Askari E. PMID: 42225513 [PubMed - as supplied by publisher]
	Lung cancer risk prediction models and asbestos exposure: a validation study on the Western Australia Asbestos Review Program. Occup Environ Med Kumarasamy C, Betts K, Norman R, Bennett K, Franklin P, Tammemägi M, Brims F. PMID: 42225416 [PubMed - as supplied by publisher]
	Online triage and cancer diagnostic activity in general practice: cross-sectional study. Br J Gen Pract Paule A, Atherton H, Parsons J, Hiller L, Abel GA. PMID: 42225391 [PubMed - as supplied by publisher]
	WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trial. BMJ Open Sharma P, Imsande KG, Vitriago A, Seibel M, Pritchett JC, Rudder B, Watson D, Beenken MJ, Tran LT, Larson SL, Flock C, Murphy CM, Puljas TL, Patten CA, Asiedu GB, Odedina FT, Lynch BA, Haddad TC. PMID: 42225362 [PubMed - in process]

Articles 1 - 20 / 1940173

Page 1 of 97009



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy